Helix BioPharma Corp. to explore growth potential

(Aurora, Ontario) – December 4, 2014 — Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Company has begun a comprehensive exploration of growth opportunities available to it.